Charles Nock is an Oncology physician affiliated with Louis Stokes Cleveland VA Medical Center. OpenAlex indexes 22 publications with 661 citations (h-index 12); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-8500Registry record last updated 29 Jun 2011.
Clinical trials
- GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
Sponsor: National Cancer Institute (NCI)
- Dasatinib in Treating Patients With Metastatic Pancreatic Cancer
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Pinnacle Biologics, IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Restrictive trial eligibility criteria as a barrier to clinical trial enrollment among veterans with aerodigestive cancers.
Journal of Clinical Oncology
2026 - Centralizing Community Care Referrals at a VA Lung Cancer Screening Program
American Journal of Respiratory and Critical Care Medicine
2025 - Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab
Journal for ImmunoTherapy of Cancer
2022 - ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449
Journal of Neuro-Oncology
2022 - Disentangling Drivers of Litter Decomposition in a Multi-Continent Network of Tree Diversity Experiments
SSRN Electronic Journal
2022
Similar KOLs
Other experts from the same institution or the same specialty.
David Canaday, MD
Louis Stokes Cleveland VA Medical Center
Elma Baron, MD
Louis Stokes Cleveland VA Medical Center
Yakov Elgudin, MD
Louis Stokes Cleveland VA Medical Center
Brian Cmolik, MD
Louis Stokes Cleveland VA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”